Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top

Journal of Thrombosis and Thrombolysis

Issue 1/2004

Special Issue on Vascular Disease: Contemporary Thoughts on the Disease and the Management Strategies

Content (8 Articles)

Multi-Bed Vascular Disease: Past, Present, and Future

William C. Dixon IV, Robert A. Harrington

Modulating Thrombotic Potential in Catheter-Based Percutaneous Coronary and Peripheral Vascular Interventions

James L. Orford, Peter B. Berger

The Efficacy and Safety of Perioperative Antiplatelet Therapy

J. Christopher Merritt, Deepak L. Bhatt

Facilitating Optimal Care of Acute Coronary, Cerebrovascular and Peripheral Vascular Syndromes in the Emergency Department: The Role of Oral Antiplatelet Therapy

Gregory A. Volturo, Richard V. Aghababian

Evolving Concepts in the Triad of Atherosclerosis, Inflammation and Thrombosis

Roberto Corti, Randolph Hutter, Juan Jose Badimon, Valentin Fuster

Utilization of Guidelines and Computer-Based Technology to Achieve Optimal Care in Atherothrombotic Vascular Disease

Christopher P. Cannon

Multi-Bed Vascular Disease and Atherothrombosis: Scope of the Problem

William Lane Duvall, David A. Vorchheimer

Patient-Specific Antiplatelet Therapy

Ian D. Conde, Neal S. Kleiman

Dec 03
Issue: 3/2003
Apr 04
Issue: 2/2004

Latest issues

scroll for more

use your arrow keys for more

scroll or use arrow keys for more

Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits